Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May not support hyperinsulinemia-targeted therapies in hypertension; leaves open multifactorial insulin resistance mechanisms for prospective study.
Alain Baron (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: